The Middle East Long Read Sequencing Market was valued at $21.7 Million in 2024 and projected to reach to $73.3 Million by 2029, representing a compound annual growth rate of 27.6%. The Middle East long read sequencing market is poised for substantial growth through 2029, driven by increasing healthcare expenditure, government support for precision medicine programs, and rising prevalence of genetic disorders requiring advanced diagnostic capabilities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The Middle East long read sequencing market is growing at 27.6% CAGR, significantly outpacing global adoption rates and demonstrating strong regional commitment to genomic innovation and precision medicine initiatives.
Major Gulf states are investing heavily in modernizing healthcare infrastructure and establishing genomic research centers, creating favorable conditions for long read sequencing technology adoption across clinical and research settings.
The region is increasingly leveraging long read sequencing for rare disease diagnosis and cancer genomics, with healthcare providers recognizing the technology's superior accuracy in detecting complex genetic variations.
Saudi Arabia and UAE are leading market drivers with combined market size of $41.5 million, positioning the Middle East as an emerging hub for advanced genomic technologies in the broader MENA region.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | DATA ANALYSIS (Workflow) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 32.8% from 2024 to 2029 |
| Largest Segment | RESEARCH USAGE (Usage) |
| Market Size Base Year (Billions) | ~USD 0.76 (2024) |
| Revenue Forecast (Billions) | ~USD 3.13 (2029) |
| Segments Covered | Offering, Technology, Workflow, Application, Usage, End User |
6 segment dimensions are covered across the global market.
| Country | 2025 size (native) |
|---|---|
| Saudi Arabia | USD 21 Million |
| UAE | USD 20.5 Million |
| GCC Countries | USD 46.6 Million |
| Rest Of Middle East | USD 26.7 Million |
The Middle East long read sequencing market was valued at $21.7 million in 2024 and is expected to reach $73.3 million by 2029.
The Middle East long read sequencing market is projected to grow at a compound annual growth rate (CAGR) of 27.6% from 2024 to 2029.
Key drivers in the Middle East include healthcare infrastructure modernization, increased precision medicine investments, government-backed genomic initiatives, and rising prevalence of genetic disorders.
Gulf Cooperation Council (GCC) nations, including the United Arab Emirates and Saudi Arabia, are leading the adoption of long read sequencing technologies in the Middle East.
The Middle East is integrating long read sequencing through collaborations between academic institutions and healthcare providers, establishment of genomic centers, and incorporation into routine clinical diagnostic workflows.
This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.
The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI), PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.
Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report